Search Results
Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference
Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference
Adjuvant Therapy | 2023 Best of Breast Conference
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference
2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy
Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures
Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review
Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review
2022 KU Post San Antonio Review | (Neo)adjuvant Therapy for Triple Negative Breast Cancer
Radiation After Lumpectomy – Determining Who Benefits: 2023 KU Breast Cancer Year in Review
Lightning Updates from Major Meetings | 2023 Best of Breast Conference
Lightning Updates | 2023 Best of Breast Conference
